The GLP-1 Shortage Is Over. Mass-Market Compounding Should Be, Too
The U.S. Food and Drug Administration’s effort to rein in mass-market copies of blockbuster GLP-1 drugs just survived a major legal challenge. Last month, the U.S. Court of Appeals for the Fifth Circuit upheld the agency’s determination that the…
